New disease model to facilitate development of ALS and MS therapies
(Karolinska Institutet) Researchers at Karolinska Institutet in Sweden have developed a new disease model for neurodegenerative diseases such as ALS and MS that can be used to develop new immunotherapies. The model is described in a publication in the scientific journal Nature Immunology.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Allergy & Immunology | Brain | Immunotherapy | International Medicine & Public Health | Neurology | Neuroscience | Sweden Health